TNF and inflammatory bowel disease: A retrospective cohort study which included 14 gastroenterologists at Haya Alhabib Gastroenterology Center, was conducted to assess the adherence to tumor necrosis factor antagonist (anti-TNF) combination therapy in patients with IBD.